Johnson & Johnson
JNJJohnson & Johnson is a global healthcare leader focused on the research, development, and manufacture of products dedicated to human health and well-being.
Earnings
Next report
Oct 13, 2026 (in a month)Segments
Competitors
By market cap
By revenue growth
By net margin
Profile
Johnson & Johnson is a global healthcare leader focused on the research, development, and manufacture of products dedicated to human health and well-being. The company operates as a holding company with a diverse portfolio spanning advanced pharmaceutical therapies and medical technologies. Its core value proposition lies in delivering innovative clinical solutions across a broad range of therapeutic areas and surgical specialties.
A leading global healthcare entity with significant market share in oncology and immunology, characterized by a massive R&D pipeline and a dominant position in the medical device market.
FAQ
- What is Johnson & Johnson's market cap?
- Johnson & Johnson (JNJ) has a market capitalization of $650.67B and trades on NYSE.
- What is Johnson & Johnson's revenue and profitability?
- Johnson & Johnson generated $97.9B in trailing twelve-month revenue with net income of $21.0B, representing a net margin of 21.5%. Gross margin stands at 67.9%, with free cash flow of $22.2B. These figures are based on the Q2 2026 filing.
- Who are Johnson & Johnson's competitors?
- Johnson & Johnson's key competitors include Merck & Co., Stryker, Pfizer, and others. These companies compete in similar markets and product categories.
- Who does Johnson & Johnson partner with?
- Johnson & Johnson's notable partners include Genmab A/S, AbbVie, Bristol-Myers Squibb, and others.
- Where is Johnson & Johnson headquartered?
- Johnson & Johnson is headquartered in United States of America and employs approximately 134,400 people. It has been publicly traded since 1944.
